Immunofluorescence assay for diagnosis of strongyloidiasis in immunocompromised patients

Carregando...
Imagem de Miniatura
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
INFORMA HEALTHCARE
Citação
INFECTIOUS DISEASES, v.47, n.8, p.550-554, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Strongyloides stercoralis is a parasite that causes human strongyloidiasis. The disease ranges from asymptomatic to severe forms, which are often fatal in immunocompromised individuals. Laboratory diagnosis is challenging owing to limitations in the use of conventional parasitological techniques. The present study aimed to evaluate the indirect immunofluorescence assay (IFA) using infective larvae of S. venezuelensis as an antigen for the immunodiagnosis of human strongyloidiasis in immunocompromised patients. Methods: Serum and stool samples from 200 immunocompromised patients (HIV-positive, HTLV-1-positive, and renal, liver, and/or bone marrow transplantation candidates) were used. Stool samples were examined using three parasitological methods: Lutz, Rugai, and culture agar plate. IFA was performed using sections of infective larvae of S. venezuelensis as antigens, and showed 95.4% sensitivity and 95.8% and specificity. Results: Among the 200 patients, 17 (8.5%) were positive for S. stercoralis by at least one parasitological method, and 43 (21.5%) were positive by IFA. Conclusions: IFA can be used as a screening method for the detection of S. stercoralis in immunocompromised patients.
Palavras-chave
Strongyloides stercoralis, immunosuppression, immunodiagnosis, indirect immunofluorescence antibody
Referências
  1. AMBROISETHOMAS P, 1976, T ROY SOC TROP MED H, V70, P107, DOI 10.1016/0035-9203(76)90164-4
  2. Boscolo M, 2007, CLIN VACCINE IMMUNOL, V14, P129, DOI 10.1128/CVI.00278-06
  3. CONWAY DJ, 1993, J INFECT DIS, V168, P784
  4. Costa-Cruz Julia Maria, 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P313, DOI 10.1590/S0036-46651997000600001
  5. Feliciano ND, 2010, DIAGN MICR INFEC DIS, V67, P153, DOI 10.1016/j.diagmicrobio.2010.01.012
  6. Grove DI, 1996, ADV PARASIT, V38, P251
  7. GROVE DI, 1981, AM J TROP MED HYG, V30, P344
  8. Ines ED, 2011, ACTA TROP, V120, P206, DOI 10.1016/j.actatropica.2011.08.010
  9. Keiser PB, 2004, CLIN MICROBIOL REV, V17, P208, DOI 10.1128/CMR.17.1.208-217.2004
  10. KOGA K, 1991, AM J TROP MED HYG, V45, P518
  11. Koosha S, 2004, Indian J Gastroenterol, V23, P214
  12. Loutfy MR, 2002, AM J TROP MED HYG, V66, P749
  13. Lutz AV., 1919, MEM I OSWALDO CRUZ, V1, P121
  14. Machado ER, 2008, EXP PARASITOL, V119, P7, DOI 10.1016/j.exppara.2007.12.008
  15. Machado ER, 2001, EXP PARASITOL, V99, P52, DOI 10.1006/expr.2001.4632
  16. Machado ER, 2008, SCAND J INFECT DIS, V40, P154, DOI 10.1080/00365540701558730
  17. Mascarello M, 2011, ANN TROP MED PARASIT, V105, P617, DOI 10.1179/2047773211Y.0000000006
  18. Mejia R, 2012, CURR OPIN INFECT DIS, V25, P458, DOI 10.1097/QCO.0b013e3283551dbd
  19. Olsen A, 2009, T ROY SOC TROP MED H, V103, P967, DOI 10.1016/j.trstmh.2009.02.013
  20. Paula FM, 2013, REV INST MED TROP SP, V55, P291
  21. Paula FM, 2000, REV INST MED TROP SP, V42, P51, DOI 10.1590/S0036.46652000000100009
  22. Paula FM, 2011, PARASITOLOGY, V138, P1331, DOI 10.1017/S003118201100120X
  23. Pirisi M, 2006, CLIN MICROBIOL INFEC, V12, P787, DOI 10.1111/j.1469-0691.2006.01500.x
  24. Requena-Mendez A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002002
  25. Rugai F, 1954, REV I A LUTZ, V14, P5
  26. Siddiqui AA, 2001, CLIN INFECT DIS, V33, P1040, DOI 10.1086/322707
  27. Uparanukraw P, 1999, AM J TROP MED HYG, V60, P967